Bankruptcy Judge Allan Gropper yesterday confirmed K-V Pharmaceutical Co.'s chapter 11 restructuring plan, which is based on a $275 million investment deal with a group of its junior bondholders, Dow Jones Daily Bankruptcy Review reported today. Judge Gropper signed off on K-V's plan after he issued a ruling Tuesday denying $32 million in interest to the company's senior bondholders, including Silver Point Capital LP.
